Literature DB >> 19240363

Muscular force is reduced in neurofibromatosis type 1.

J F Souza1, R L F Passos, A C M Guedes, N A Rezende, L O C Rodrigues.   

Abstract

OBJECTIVES: To measure muscular force in neurofibromatosis type 1 (NF1) patients.
METHODS: The maximal voluntary muscular force (F(max)) was measured in the first 21 volunteer patients without acute health problems at the routine annual examination in the Neurofibromatosis Outpatient Reference Center during October-November (2007). The NF1 individuals were 9 males and 12 females, aged from 7 to 60 years and physically sedentary. The healthy control group was 21 healthy subjects matched to NF1 group by age, sex and physical activity. A handgrip test instrument was used to measure maximal force. To allow comparisons between physically different patients, forearm circumference (cm) was measured with a tape and forearm cross sectional area was derived to express the force per unit of forearm area. Data were compared using a t Student test (P<0.05).
RESULTS: The mean F(max) of NF1 male (260-/+136 N) and NF1 female (217-/+76 N) were lower than expected for their sex and age. Healthy men showed greater F(area) (9.8-/+3.2 N x cm(-2)) than NF1 men (5.7-/+2.6 N x cm(-2)) and healthy women (6.7-/+1.6 N x cm(-2)) showed greater F(area) than NF1 females (5.7-/+1.9 N x cm(-2)).
CONCLUSION: Maximal voluntary muscle force was reduced in NF1 patients.

Entities:  

Mesh:

Year:  2009        PMID: 19240363

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  9 in total

1.  Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1.

Authors:  Barbara A Johnson; Bruce Macwilliams; John C Carey; David H Viskochil; Jacques L D'Astous; David A Stevenson
Journal:  Hum Mov Sci       Date:  2011-09-08       Impact factor: 2.161

2.  Neurofibromin (Nf1) is required for skeletal muscle development.

Authors:  Nadine Kossler; Sigmar Stricker; Christian Rödelsperger; Peter N Robinson; Johnny Kim; Carola Dietrich; Monika Osswald; Jirko Kühnisch; David A Stevenson; Thomas Braun; Stefan Mundlos; Mateusz Kolanczyk
Journal:  Hum Mol Genet       Date:  2011-04-09       Impact factor: 6.150

3.  Motor proficiency in children with neurofibromatosis type 1.

Authors:  Barbara A Johnson; Bruce A MacWilliams; John C Carey; David H Viskochil; Jacques L D'Astous; David A Stevenson
Journal:  Pediatr Phys Ther       Date:  2010       Impact factor: 3.049

4.  Improved renal function in neurofibromatosis type 1 patients.

Authors:  Ken-Ichi Yasuda; Yoshimasa Nobeyama; Akihiko Asahina
Journal:  Skin Health Dis       Date:  2022-05-02

5.  NF1 is a critical regulator of muscle development and metabolism.

Authors:  Kate Sullivan; Jad El-Hoss; Kate G R Quinlan; Nikita Deo; Fleur Garton; Jane T C Seto; Marie Gdalevitch; Nigel Turner; Gregory J Cooney; Mateusz Kolanczyk; Kathryn N North; David G Little; Aaron Schindeler
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

Review 6.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Authors:  M A Summers; K G Quinlan; J M Payne; D G Little; K N North; A Schindeler
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

Review 7.  The skeletal muscle phenotype of children with Neurofibromatosis Type 1 - A clinical perspective.

Authors:  Amish Chinoy; Grace R Vassallo; Emma Burkitt Wright; Judith Eelloo; Siobhan West; Eileen Hupton; Paula Galloway; Amy Pilkington; Raja Padidela; M Zulf Mughal
Journal:  J Musculoskelet Neuronal Interact       Date:  2022-03-01       Impact factor: 1.864

8.  Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.

Authors:  Srivandana Akshintala; Nashwa Khalil; Kaleb Yohay; Alona Muzikansky; Jeffrey Allen; Anna Yaffe; Andrea M Gross; Michael J Fisher; Jaishri O Blakeley; Beverly Oberlander; Miriam Pudel; Celia Engelson; Jaime Obletz; Carole Mitchell; Brigitte C Widemann; David A Stevenson; Scott R Plotkin
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

9.  Attention and Motor Learning in Adult Patients with Neurofibromatosis Type 1.

Authors:  Jesminne Castricum; Joke H M Tulen; Walter Taal; André B Rietman; Ype Elgersma
Journal:  J Atten Disord       Date:  2021-05-12       Impact factor: 3.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.